Literature DB >> 30242125

Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.

Hilary A Weismiller1, Rachel Murphy1, Guanghong Wei2, Buyong Ma3, Ruth Nussinov3,4, Martin Margittai5.   

Abstract

The intracellular deposition of fibrils composed of the microtubule-associated protein Tau is a characteristic feature of Alzheimer's disease (AD) and other fatal neurodegenerative disorders collectively known as tauopathies. Short Tau fibrils spread intracerebrally through transfer between interconnected neurons. Once taken up by a recipient cell, Tau fibrils recruit Tau monomers onto their ends. Based on the number of microtubule-binding repeats, there are two distinct groups of Tau isoforms: three-repeat (3R) Tau and four-repeat (4R) Tau. In AD, all Tau isoforms are deposited, whereas in other tauopathies, only 3R or 4R Tau isoforms are deposited. The molecular basis for these isoform-specific depositions is poorly understood, although conformation-based cross-seeding barriers are key. Here, we used sedimentation assays, EPR spectroscopy, and other structural readouts to better understand the cross-seeding barriers of 4R Tau fibrils. We observed that fibrils formed from truncated Tau (K18), but not full-length Tau (htau40), exhibit a barrier that inhibits 3R Tau recruitment. Investigating an array of differently sized fragments, we found that the Tau C terminus modulates the cross-seeding barrier and that the N terminus plays a synergistic role. Two disease-associated Tau variants, P301S and P301L, also established strong cross-seeding barriers. EPR analysis indicated that fibrils seeded with truncated and mutated Tau, but not htau40, are structurally disordered in the second half of repeat four and onward. These findings suggest that the disorder in this region diminishes the ability of 4R Tau fibrils to recruit 3R Tau monomers, revealing a new mechanism for Tau cross-seeding barriers.

Entities:  

Keywords:  Alzheimer disease; Tau protein (Tau); amyloid; conformational change; electron paramagnetic resonance (EPR); fibril; prion; protein aggregation; protein structure; seeding barrier; tauopathy

Mesh:

Substances:

Year:  2018        PMID: 30242125      PMCID: PMC6231118          DOI: 10.1074/jbc.RA118.005316

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Electron paramagnetic resonance spectroscopy measures the distance between the external β-strands of folded α-synuclein in amyloid fibrils.

Authors:  Irina Karyagina; Stefan Becker; Karin Giller; Dietmar Riedel; Thomas M Jovin; Christian Griesinger; Marina Bennati
Journal:  Biophys J       Date:  2011-07-06       Impact factor: 4.033

2.  Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure.

Authors:  O Schweers; E Schönbrunn-Hanebeck; A Marx; E Mandelkow
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

3.  Investigation of alpha-synuclein fibril structure by site-directed spin labeling.

Authors:  Min Chen; Martin Margittai; Jeannie Chen; Ralf Langen
Journal:  J Biol Chem       Date:  2007-06-15       Impact factor: 5.157

4.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

5.  Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau.

Authors:  Hirofumi Aoyagi; Masato Hasegawa; Akira Tamaoka
Journal:  J Biol Chem       Date:  2007-05-25       Impact factor: 5.157

6.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

7.  Deep clinical and neuropathological phenotyping of Pick disease.

Authors:  David J Irwin; Johannes Brettschneider; Corey T McMillan; Felicia Cooper; Christopher Olm; Steven E Arnold; Vivianna M Van Deerlin; William W Seeley; Bruce L Miller; Edward B Lee; Virginia M-Y Lee; Murray Grossman; John Q Trojanowski
Journal:  Ann Neurol       Date:  2015-12-25       Impact factor: 10.422

8.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

9.  Fracture and Growth Are Competing Forces Determining the Fate of Conformers in Tau Fibril Populations.

Authors:  Virginia Meyer; Michael R Holden; Hilary A Weismiller; Gareth R Eaton; Sandra S Eaton; Martin Margittai
Journal:  J Biol Chem       Date:  2016-04-14       Impact factor: 5.157

10.  Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.

Authors:  Jing L Guo; Sneha Narasimhan; Lakshmi Changolkar; Zhuohao He; Anna Stieber; Bin Zhang; Ronald J Gathagan; Michiyo Iba; Jennifer D McBride; John Q Trojanowski; Virginia M Y Lee
Journal:  J Exp Med       Date:  2016-10-17       Impact factor: 14.307

View more
  17 in total

1.  In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments.

Authors:  Aurelio J Dregni; Venkata S Mandala; Haifan Wu; Matthew R Elkins; Harrison K Wang; Ivan Hung; William F DeGrado; Mei Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

2.  Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation.

Authors:  Solomiia Boyko; Krystyna Surewicz; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-01       Impact factor: 11.205

3.  Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.

Authors:  Paul Matthew Seidler; David R Boyer; Kevin A Murray; Tianxiao P Yang; Megan Bentzel; Michael R Sawaya; Gregory Rosenberg; Duilio Cascio; Christopher Kazu Williams; Kathy L Newell; Bernardino Ghetti; Michael A DeTure; Dennis W Dickson; Harry V Vinters; David S Eisenberg
Journal:  J Biol Chem       Date:  2019-09-19       Impact factor: 5.157

4.  Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.

Authors:  Longfei Li; Yanli Jiang; Wen Hu; Yunn Chyn Tung; Chunling Dai; Dandan Chu; Cheng-Xin Gong; Khalid Iqbal; Fei Liu
Journal:  Mol Neurobiol       Date:  2019-02-08       Impact factor: 5.590

Review 5.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 6.  The propagation mechanisms of extracellular tau in Alzheimer's disease.

Authors:  Yun Wei; Meixia Liu; Dongxin Wang
Journal:  J Neurol       Date:  2021-04-28       Impact factor: 4.849

Review 7.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

8.  Misfolding and Self-Assembly Dynamics of Microtubule-Binding Repeats of the Alzheimer-Related Protein Tau.

Authors:  Huan He; Yuying Liu; Yunxiang Sun; Feng Ding
Journal:  J Chem Inf Model       Date:  2021-05-25       Impact factor: 6.162

9.  Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases.

Authors:  Wenjuan Zhang; Benjamin Falcon; Alexey G Murzin; Juan Fan; R Anthony Crowther; Michel Goedert; Sjors Hw Scheres
Journal:  Elife       Date:  2019-02-05       Impact factor: 8.140

Review 10.  Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration.

Authors:  Carlo Scialò; Elena De Cecco; Paolo Manganotti; Giuseppe Legname
Journal:  Viruses       Date:  2019-03-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.